Skip to content

Steve E. Krognes, Director at Guardant Health, sold GH on Sep 16, 2026

Data as of Oct 16

▼ SELL$192K1,103 shares at $174.46Steve E. Krognes DirectorGH Guardant Health, Inc.
Watch GH
Traded
Sep 16, 2026
Disclosed
Sep 17, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Steve E. Krognes, Director at Guardant Health, sold GH on Sep 16, 2026TRADEDDISCLOSED
GHSimilar stocks (XLV — its sector index fund), rebased to GH's price on the disclosure day
GH since disclosure
−13.4%
after the sale
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund

Change in closing price from Sep 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSteve E. Krognes DirectorGH Guardant Health, Inc.$229Kdisclosed Sep 17 · filed 1 day after the trade
  2. ▼ SELLSteve E. Krognes DirectorGH Guardant Health, Inc.$579Kdisclosed Sep 17 · filed 1 day after the trade
  3. ▼ SELLSteve E. Krognes DirectorGH Guardant Health, Inc.$172Kdisclosed Sep 17 · filed 1 day after the trade

See every trade on GH →